Status:
COMPLETED
Race, Ethnicity, and Diffuse Parenchymal Lung Disease
Lead Sponsor:
Columbia University
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Idiopathic Pulmonary Fibrosis
Interstitial Lung Disease
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to identify factors that contribute to higher mortality rates among blacks and Hispanics with diffuse parenchymal lung disease.
Detailed Description
It is well known that both socioeconomic and biological factors may contribute to race- and ethnicity-based health disparities. Black and Hispanic Americans have worse access to healthcare services an...
Eligibility Criteria
Inclusion
- Diagnosis of IPF or other DPLD according to ATS criteria
- Signed informed consent
Exclusion
- None
Key Trial Info
Start Date :
July 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2013
Estimated Enrollment :
565 Patients enrolled
Trial Details
Trial ID
NCT00453713
Start Date
July 1 2006
End Date
August 1 2013
Last Update
April 21 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University Medical Center
New York, New York, United States, 10032